APO Research
Talk to an analyst

APO RESEARCH · REPORT

Octreotide

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.

Selected research

Market Outlook & Growth Opportunities

Global Octreotide Market Outlook and Growth Opportunities 2026

22 December 2025199 pages

Choose your research edition.

Industry ResearchOctreotide Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Octreotide Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Octreotide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Octreotide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Octreotide Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.

Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.

Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.

Read the full market overview

This report provides an overview of the global Octreotide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Octreotide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Octreotide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Octreotide market size, projected growth trends, production technologies, key applications, and end-use industries.

Octreotide Segment by Company

Novartis

Sun Pharmaceutical

Chengdu Tiantaishan pharmaceutical

Sinopharm A-Think Pharmaceuticals

Sihuan Pharmaceutical Holdings Group

Shanghai Soho-Yiming Pharmaceuticals

Yibin Pharmaceutical

Octreotide Segment by Type

Octreotide Injection

Octreotide Powder

Octreotide Microspheres

Octreotide Segment by Application

Treating Severe Diarrhea

Treating Acromegaly

Others

Octreotide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Octreotide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Octreotide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Octreotide significant trends, drivers, influence factors in global and regions.

6. To analyze Octreotide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Octreotide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Octreotide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Octreotide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Octreotide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Octreotide industry.

Chapter 3: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Octreotide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Octreotide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Octreotide Industry Trends Table 2. Octreotide Industry Drivers Table 3. Octreotide Industry Opportunities and Challenges Table 4. Octreotide Industry Restraints Table 5. Global Octreotide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Octreotide Revenue Share by Company (2021-2026) Table 7. Global Octreotide Sales Volume by Company (Gram) & (2021-2026) Table 8. Global Octreotide Sales Volume Share by Company (2021-2026) Table 9. Global Octreotide Average Price (USD/Gram) of Company (2021-2026) Table 10. Global Octreotide Company Ranking, (2024-2026) & (USD Million) Table 11. Global Octreotide Key Company Manufacturing Base & Headquarters Table 12. Global Octreotide Company, Product Type & Application Table 13. Global Octreotide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Octreotide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Octreotide Injection Table 18. Significant Companies of Octreotide Powder Table 19. Significant Companies of Octreotide Microspheres Table 20. Global Octreotide Sales Volume by Type 2021 VS 2025 VS 2032 (Gram) Table 21. Global Octreotide Sales Volume by Type (2021-2026) & (Gram) Table 22. Global Octreotide Sales Volume by Type (2027-2032) & (Gram) Table 23. Global Octreotide Sales Volume Share by Type (2021-2026) Table 24. Global Octreotide Sales Volume Share by Type (2027-2032) Table 25. Global Octreotide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Octreotide Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Octreotide Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Octreotide Sales Value Share by Type (2021-2026) Table 29. Global Octreotide Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Treating Severe Diarrhea Table 31. Significant Companies of Treating Acromegaly Table 32. Significant Companies of Others Table 33. Global Octreotide Sales Volume by Application 2021 VS 2025 VS 2032 (Gram) Table 34. Global Octreotide Sales Volume by Application (2021-2026) & (Gram) Table 35. Global Octreotide Sales Volume by Application (2027-2032) & (Gram) Table 36. Global Octreotide Sales Volume Share by Application (2021-2026) Table 37. Global Octreotide Sales Volume Share by Application (2027-2032) Table 38. Global Octreotide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Octreotide Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Octreotide Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Octreotide Sales Value Share by Application (2021-2026) Table 42. Global Octreotide Sales Value Share by Application (2027-2032) Table 43. Global Octreotide Sales by Region: 2021 VS 2025 VS 2032 (Gram) Table 44. Global Octreotide Sales by Region (2021-2026) & (Gram) Table 45. Global Octreotide Sales Market Share by Region (2021-2026) Table 46. Global Octreotide Sales by Region (2027-2032) & (Gram) Table 47. Global Octreotide Sales Market Share by Region (2027-2032) Table 48. Global Octreotide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Octreotide Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Octreotide Sales Value Share by Region (2021-2026) Table 51. Global Octreotide Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Octreotide Sales Value Share by Region (2027-2032) Table 53. Global Octreotide Market Average Price (USD/Gram) by Region (2021-2026) Table 54. Global Octreotide Market Average Price (USD/Gram) by Region (2027-2032) Table 55. Global Octreotide Sales by Country: 2021 VS 2025 VS 2032 (Gram) Table 56. Global Octreotide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Octreotide Sales by Country (2021-2026) & (Gram) Table 58. Global Octreotide Sales Market Share by Country (2021-2026) Table 59. Global Octreotide Sales by Country (2027-2032) & (Gram) Table 60. Global Octreotide Sales Market Share by Country (2027-2032) Table 61. Global Octreotide Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Octreotide Sales Value Market Share by Country (2021-2026) Table 63. Global Octreotide Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Octreotide Sales Value Market Share by Country (2027-2032) Table 65. Novartis Company Information Table 66. Novartis Business Overview Table 67. Novartis Octreotide Sales (Gram), Value (US$ Million), Price (USD/Gram) and Gross Margin (2021-2026) Table 68. Novartis Octreotide Product Portfolio Table 69. Novartis Recent Development Table 70. Sun Pharmaceutical Company Information Table 71. Sun Pharmaceutical Business Overview Table 72. Sun Pharmaceutical Octreotide Sales (Gram), Value (US$ Million), Price (USD/Gram) and Gross Margin (2021-2026) Table 73. Sun Pharmaceutical Octreotide Product Portfolio Table 74. Sun Pharmaceutical Recent Development Table 75. Chengdu Tiantaishan pharmaceutical Company Information Table 76. Chengdu Tiantaishan pharmaceutical Business Overview Table 77. Chengdu Tiantaishan pharmaceutical Octreotide Sales (Gram), Value (US$ Million), Price (USD/Gram) and Gross Margin (2021-2026) Table 78. Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolio Table 79. Chengdu Tiantaishan pharmaceutical Recent Development Table 80. Sinopharm A-Think Pharmaceuticals Company Information Table 81. Sinopharm A-Think Pharmaceuticals Business Overview Table 82. Sinopharm A-Think Pharmaceuticals Octreotide Sales (Gram), Value (US$ Million), Price (USD/Gram) and Gross Margin (2021-2026) Table 83. Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolio Table 84. Sinopharm A-Think Pharmaceuticals Recent Development Table 85. Sihuan Pharmaceutical Holdings Group Company Information Table 86. Sihuan Pharmaceutical Holdings Group Business Overview Table 87. Sihuan Pharmaceutical Holdings Group Octreotide Sales (Gram), Value (US$ Million), Price (USD/Gram) and Gross Margin (2021-2026) Table 88. Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolio Table 89. Sihuan Pharmaceutical Holdings Group Recent Development Table 90. Shanghai Soho-Yiming Pharmaceuticals Company Information Table 91. Shanghai Soho-Yiming Pharmaceuticals Business Overview Table 92. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales (Gram), Value (US$ Million), Price (USD/Gram) and Gross Margin (2021-2026) Table 93. Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolio Table 94. Shanghai Soho-Yiming Pharmaceuticals Recent Development Table 95. Yibin Pharmaceutical Company Information Table 96. Yibin Pharmaceutical Business Overview Table 97. Yibin Pharmaceutical Octreotide Sales (Gram), Value (US$ Million), Price (USD/Gram) and Gross Margin (2021-2026) Table 98. Yibin Pharmaceutical Octreotide Product Portfolio Table 99. Yibin Pharmaceutical Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Octreotide Distributors List Table 103. Octreotide Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Octreotide Product Image Figure 2. Global Octreotide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Octreotide Sales Value (2021-2032) & (US$ Million) Figure 4. Global Octreotide Sales (2021-2032) & (Gram) Figure 5. Global Octreotide Sales Average Price (USD/Gram) & (2021-2032) Figure 6. Global Octreotide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Octreotide Injection Image Figure 10. Octreotide Powder Image Figure 11. Octreotide Microspheres Image Figure 12. Global Octreotide Sales Volume by Type (2021 VS 2025 VS 2032) & (Gram) Figure 13. Global Octreotide Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Octreotide Sales Volume Share by Type (2021-2032) Figure 15. Global Octreotide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Octreotide Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Octreotide Sales Value Share by Type (2021-2032) Figure 18. Treating Severe Diarrhea Image Figure 19. Treating Acromegaly Image Figure 20. Others Image Figure 21. Global Octreotide Sales Volume by Application (2021 VS 2025 VS 2032) & (Gram) Figure 22. Global Octreotide Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Octreotide Sales Volume Share by Application (2021-2032) Figure 24. Global Octreotide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Octreotide Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Octreotide Sales Value Share by Application (2021-2032) Figure 27. Global Octreotide Sales by Region: 2021 VS 2025 VS 2032 (Gram) Figure 28. Global Octreotide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Octreotide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Octreotide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Octreotide Sales Value (2021-2032) & (US$ Million) Figure 32. North America Octreotide Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Octreotide Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Octreotide Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Octreotide Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Octreotide Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Octreotide Sales Value (2021-2032) & (US$ Million) Figure 38. South America Octreotide Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Octreotide Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Octreotide Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Octreotide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Octreotide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Octreotide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Octreotide Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Octreotide Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Octreotide Injection
  • Octreotide Powder
  • Octreotide Microspheres
Applications
  • Treating Severe Diarrhea
  • Treating Acromegaly
  • Others
Companies covered
  • Novartis
  • Sun Pharmaceutical
  • Chengdu Tiantaishan pharmaceutical
  • Sinopharm A-Think Pharmaceuticals
  • Sihuan Pharmaceutical Holdings Group
  • Shanghai Soho-Yiming Pharmaceuticals
  • Yibin Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Octreotide Sales Value (2021-2032)
  4. 1.2.2 Global Octreotide Sales Volume (2021-2032)
  5. 1.2.3 Global Octreotide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Octreotide Market Dynamics
  1. 2.1 Octreotide Industry Trends
  2. 2.2 Octreotide Industry Drivers
  3. 2.3 Octreotide Industry Opportunities and Challenges
  4. 2.4 Octreotide Industry Restraints
3 Octreotide Market by Company
  1. 3.1 Global Octreotide Company Revenue Ranking in 2025
  2. 3.2 Global Octreotide Revenue by Company (2021-2026)
  3. 3.3 Global Octreotide Sales Volume by Company (2021-2026)
  4. 3.4 Global Octreotide Average Price by Company (2021-2026)
  5. 3.5 Global Octreotide Company Ranking (2024-2026)
  6. 3.6 Global Octreotide Company Manufacturing Base and Headquarters
  7. 3.7 Global Octreotide Company Product Type and Application
  8. 3.8 Global Octreotide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Octreotide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Octreotide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Octreotide Market by Type
  1. 4.1 Octreotide Type Introduction
  2. 4.1.1 Octreotide Injection
  3. 4.1.2 Octreotide Powder
  4. 4.1.3 Octreotide Microspheres
  5. 4.2 Global Octreotide Sales Volume by Type
  6. 4.2.1 Global Octreotide Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Octreotide Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Octreotide Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Octreotide Sales Value by Type
  10. 4.3.1 Global Octreotide Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Octreotide Sales Value by Type (2021-2032)
  12. 4.3.3 Global Octreotide Sales Value Share by Type (2021-2032)
5 Octreotide Market by Application
  1. 5.1 Octreotide Application Introduction
  2. 5.1.1 Treating Severe Diarrhea
  3. 5.1.2 Treating Acromegaly
  4. 5.1.3 Others
  5. 5.2 Global Octreotide Sales Volume by Application
  6. 5.2.1 Global Octreotide Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Octreotide Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Octreotide Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Octreotide Sales Value by Application
  10. 5.3.1 Global Octreotide Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Octreotide Sales Value by Application (2021-2032)
  12. 5.3.3 Global Octreotide Sales Value Share by Application (2021-2032)
6 Octreotide Regional Sales and Value Analysis
  1. 6.1 Global Octreotide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Octreotide Sales by Region (2021-2032)
  3. 6.2.1 Global Octreotide Sales by Region: 2021-2026
  4. 6.2.2 Global Octreotide Sales by Region (2027-2032)
  5. 6.3 Global Octreotide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Octreotide Sales Value by Region (2021-2032)
  7. 6.4.1 Global Octreotide Sales Value by Region: 2021-2026
  8. 6.4.2 Global Octreotide Sales Value by Region (2027-2032)
  9. 6.5 Global Octreotide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Octreotide Sales Value (2021-2032)
  12. 6.6.2 North America Octreotide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Octreotide Sales Value (2021-2032)
  15. 6.7.2 Europe Octreotide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Octreotide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Octreotide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Octreotide Sales Value (2021-2032)
  21. 6.9.2 South America Octreotide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Octreotide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Octreotide Sales Value Share by Country, 2025 VS 2032
7 Octreotide Country-level Sales and Value Analysis
  1. 7.1 Global Octreotide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Octreotide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Octreotide Sales by Country (2021-2032)
  4. 7.3.1 Global Octreotide Sales by Country (2021-2026)
  5. 7.3.2 Global Octreotide Sales by Country (2027-2032)
  6. 7.4 Global Octreotide Sales Value by Country (2021-2032)
  7. 7.4.1 Global Octreotide Sales Value by Country (2021-2026)
  8. 7.4.2 Global Octreotide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Octreotide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Octreotide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Octreotide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Octreotide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Octreotide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Octreotide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Octreotide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Octreotide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Octreotide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Octreotide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Octreotide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Octreotide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Octreotide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Octreotide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Octreotide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Octreotide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Octreotide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Octreotide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Octreotide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Octreotide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Octreotide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Octreotide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Octreotide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Octreotide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Octreotide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Octreotide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Octreotide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Octreotide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Octreotide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Octreotide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Octreotide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Octreotide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Octreotide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Octreotide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Octreotide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Octreotide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Octreotide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Octreotide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Octreotide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Octreotide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Octreotide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Octreotide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Octreotide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Octreotide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Octreotide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Octreotide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Octreotide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Octreotide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Octreotide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Octreotide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Octreotide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Octreotide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Octreotide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Octreotide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Octreotide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Octreotide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Octreotide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Octreotide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Octreotide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Octreotide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Octreotide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Octreotide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Octreotide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Octreotide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Octreotide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Octreotide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Octreotide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Octreotide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Octreotide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Octreotide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Octreotide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Octreotide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Octreotide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Octreotide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Octreotide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Octreotide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Octreotide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Octreotide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Octreotide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Octreotide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Octreotide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Octreotide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Octreotide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Octreotide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Octreotide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Octreotide Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Sun Pharmaceutical
  8. 8.2.1 Sun Pharmaceutical Company Information
  9. 8.2.2 Sun Pharmaceutical Business Overview
  10. 8.2.3 Sun Pharmaceutical Octreotide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Octreotide Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Recent Developments
  13. 8.3 Chengdu Tiantaishan pharmaceutical
  14. 8.3.1 Chengdu Tiantaishan pharmaceutical Company Information
  15. 8.3.2 Chengdu Tiantaishan pharmaceutical Business Overview
  16. 8.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolio
  18. 8.3.5 Chengdu Tiantaishan pharmaceutical Recent Developments
  19. 8.4 Sinopharm A-Think Pharmaceuticals
  20. 8.4.1 Sinopharm A-Think Pharmaceuticals Company Information
  21. 8.4.2 Sinopharm A-Think Pharmaceuticals Business Overview
  22. 8.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolio
  24. 8.4.5 Sinopharm A-Think Pharmaceuticals Recent Developments
  25. 8.5 Sihuan Pharmaceutical Holdings Group
  26. 8.5.1 Sihuan Pharmaceutical Holdings Group Company Information
  27. 8.5.2 Sihuan Pharmaceutical Holdings Group Business Overview
  28. 8.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolio
  30. 8.5.5 Sihuan Pharmaceutical Holdings Group Recent Developments
  31. 8.6 Shanghai Soho-Yiming Pharmaceuticals
  32. 8.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
  33. 8.6.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
  34. 8.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolio
  36. 8.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
  37. 8.7 Yibin Pharmaceutical
  38. 8.7.1 Yibin Pharmaceutical Company Information
  39. 8.7.2 Yibin Pharmaceutical Business Overview
  40. 8.7.3 Yibin Pharmaceutical Octreotide Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Yibin Pharmaceutical Octreotide Product Portfolio
  42. 8.7.5 Yibin Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Octreotide Value Chain Analysis
  2. 9.1.1 Octreotide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Octreotide Sales Mode & Process
  6. 9.2 Octreotide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Octreotide Distributors
  9. 9.2.3 Octreotide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst